105 related articles for article (PubMed ID: 8356598)
1. Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice.
Xun C; Brown SA; Jennings CD; Henslee-Downey PJ; Thompson JS
Transplantation; 1993 Aug; 56(2):409-17. PubMed ID: 8356598
[TBL] [Abstract][Full Text] [Related]
2. Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells.
Zhai YF; Esselman WJ; Oakley CS; Chang CC; Welsch CW
Cancer Immunol Immunother; 1992; 35(4):237-45. PubMed ID: 1511458
[TBL] [Abstract][Full Text] [Related]
3. The CySF-L2 factor from dialysable human leucocyte extract activates natural killer cytotoxicity by induction of interferon gamma.
Doelker I; Anderer FA
Cancer Immunol Immunother; 1992; 34(5):299-305. PubMed ID: 1540976
[TBL] [Abstract][Full Text] [Related]
4. GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo.
Lim O; Lee Y; Chung H; Her JH; Kang SM; Jung MY; Min B; Shin H; Kim TM; Heo DS; Hwang YK; Shin EC
PLoS One; 2013; 8(1):e53611. PubMed ID: 23326467
[TBL] [Abstract][Full Text] [Related]
5. A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer.
Mueller EA; Anderer FA
Cancer Immunol Immunother; 1990; 32(4):221-7. PubMed ID: 2124513
[TBL] [Abstract][Full Text] [Related]
6. A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.
Sarhan D; Wennerberg E; D'Arcy P; Gurajada D; Linder S; Lundqvist A
Cancer Immunol Immunother; 2013 Aug; 62(8):1359-68. PubMed ID: 23689729
[TBL] [Abstract][Full Text] [Related]
7. Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells.
Alosco T; Croy BA; Gansbacher B; Wang HQ; Rao U; Bankert R
Cancer Immunol Immunother; 1993 Jun; 36(6):364-72. PubMed ID: 8500109
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.
Razmara AM; Farley LE; Harris RM; Judge SJ; Lammers M; Iranpur KR; Johnson EG; Dunai C; Murphy WJ; Brown CT; Rebhun RB; Kent MS; Canter RJ
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631708
[TBL] [Abstract][Full Text] [Related]
9. Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose.
Palmer PA; Scharenberg JG; von Blomberg BM; Stam AG; Meijer CJ; Roest GJ; Franks CR; Scheper RJ
Cancer Immunol Immunother; 1994 Jul; 39(1):34-40. PubMed ID: 8044824
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.
Orleans-Lindsay JK; Barber LD; Prentice HG; Lowdell MW
Clin Exp Immunol; 2001 Dec; 126(3):403-11. PubMed ID: 11737054
[TBL] [Abstract][Full Text] [Related]
11. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma.
Kawarabayashi N; Seki S; Hatsuse K; Ohkawa T; Koike Y; Aihara T; Habu Y; Nakagawa R; Ami K; Hiraide H; Mochizuki H
Hepatology; 2000 Nov; 32(5):962-9. PubMed ID: 11050046
[TBL] [Abstract][Full Text] [Related]
12. Patients' NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing.
Belounis A; Ayoub M; Cordeiro P; Lemieux W; Teira P; Haddad E; Herblot S; Duval M
Cancer Immunol Immunother; 2020 Sep; 69(9):1767-1779. PubMed ID: 32342128
[TBL] [Abstract][Full Text] [Related]
13. Unique patterns of CD8+ T-cell-mediated organ damage in the Act-mOVA/OT-I model of acute graft-versus-host disease.
Érsek B; Lupsa N; Pócza P; Tóth A; Horváth A; Molnár V; Bagita B; Bencsik A; Hegyesi H; Matolcsy A; Buzás EI; Pós Z
Cell Mol Life Sci; 2016 Oct; 73(20):3935-47. PubMed ID: 27137185
[TBL] [Abstract][Full Text] [Related]
14. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.
Dewan MZ; Terunuma H; Toi M; Tanaka Y; Katano H; Deng X; Abe H; Nakasone T; Mori N; Sata T; Yamamoto N
Cancer Sci; 2006 Dec; 97(12):1381-7. PubMed ID: 16995875
[TBL] [Abstract][Full Text] [Related]
15. Feeder cells enhance oncolytic and proliferative activity of long-term human bone marrow interleukin-2 cultures and induce different lymphocyte subsets.
Fuchshuber PR; Lotzová E
Cancer Immunol Immunother; 1991; 33(1):15-20. PubMed ID: 2021955
[TBL] [Abstract][Full Text] [Related]
16. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity.
Nishimura R; Baker J; Beilhack A; Zeiser R; Olson JA; Sega EI; Karimi M; Negrin RS
Blood; 2008 Sep; 112(6):2563-74. PubMed ID: 18565854
[TBL] [Abstract][Full Text] [Related]
17. Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method.
Leung W; Iyengar R; Leimig T; Holladay MS; Houston J; Handgretinger R
Cancer Immunol Immunother; 2005 Apr; 54(4):389-94. PubMed ID: 15449041
[TBL] [Abstract][Full Text] [Related]
18. Obese donor mice splenocytes aggravated the pathogenesis of acute graft-versus-host disease via regulating differentiation of Tregs and CD4
Li Z; Gu J; Zhu Q; Liu J; Lu H; Lu Y; Wang X
Oncotarget; 2017 Sep; 8(43):74880-74896. PubMed ID: 29088831
[TBL] [Abstract][Full Text] [Related]
19. Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes.
Rabinovich PM; Komarovskaya ME; Wrzesinski SH; Alderman JL; Budak-Alpdogan T; Karpikov A; Guo H; Flavell RA; Cheung NK; Weissman SM; Bahceci E
Hum Gene Ther; 2009 Jan; 20(1):51-61. PubMed ID: 19025415
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the anti-tumor function of adoptively transferred NK cells in vivo.
Pegram HJ; Haynes NM; Smyth MJ; Kershaw MH; Darcy PK
Cancer Immunol Immunother; 2010 Aug; 59(8):1235-46. PubMed ID: 20376439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
